Home Applications 216683 Application 216683
Type ANDA
Sponsor RUBICON RESEARCH Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TOPIRAMATE TOPIRAMATE CAPSULE;ORAL 15MG No No 002 TOPIRAMATE TOPIRAMATE CAPSULE;ORAL 25MG No No 003 TOPIRAMATE TOPIRAMATE CAPSULE;ORAL 50MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A216683-001 TOPIRAMATE TOPIRAMATE 15MG CAPSULE / ORAL AB 2025-05-27 A216683-002 TOPIRAMATE TOPIRAMATE 25MG CAPSULE / ORAL AB 2025-05-27 A216683-003 TOPIRAMATE TOPIRAMATE 50MG CAPSULE / ORAL AB 2025-05-27
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration A216683-003 CGT 2026-02-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A216683-001 TOPIRAMATE 15MG CAPSULE / ORAL AB 2025-05-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A216683-002 TOPIRAMATE 25MG CAPSULE / ORAL AB 2025-05-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A216683-003 TOPIRAMATE 50MG CAPSULE / ORAL AB 2025-05-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A216683-001 TOPIRAMATE 15MG CAPSULE / ORAL AB 2025-05-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A216683-002 TOPIRAMATE 25MG CAPSULE / ORAL AB 2025-05-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A216683-003 TOPIRAMATE 50MG CAPSULE / ORAL AB 2025-05-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A216683-001 TOPIRAMATE 15MG CAPSULE / ORAL AB 2025-05-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A216683-002 TOPIRAMATE 25MG CAPSULE / ORAL AB 2025-05-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A216683-003 TOPIRAMATE 50MG CAPSULE / ORAL AB 2025-05-27 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A216683-001 TOPIRAMATE 15MG CAPSULE / ORAL AB 2025-05-27 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A216683-002 TOPIRAMATE 25MG CAPSULE / ORAL AB 2025-05-27 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A216683-003 TOPIRAMATE 50MG CAPSULE / ORAL AB 2025-05-27 a50c72e98297…
Observed Orange Book normalized TE history# Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 A216683-003 CGT 2026-02-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A216683-003 CGT 2026-02-01 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A216683-003 CGT 2026-02-01 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.